Resource Centre
Learning 
Which library prep workflow is right for my experiment?
Poster 
Validation and application of multiplex nanopore MinION sequencing for molecular typing of human adenoviruses in clinical samples: a cost effective sequencing strategy
Video 
Utility of long-read whole-genome sequencing across diverse clinical genomic investigations: a single- center experience | LC26
Video 
Understanding the role of rRNA modifications in colorectal cancer | LC26
Video 
Understanding population-scale structural variation using long-read genomics | LC26
Video 
Towards routine modopathy diagnostics: advances and clinical application of direct RNA sequencing
Video 
Stepping into the future of nanopore protein sequencing
Video 
Stencilling accessible chromatin fibres reveals haplotype-specific regulation
Learning 
Start the timer: how do I prepare a sequencing library in ten minutes?
Publication 
Single-cell rapid capture hybridization sequencing (scRaCH-seq) to reliably detect isoform usage and coding mutations in targeted genes at a single-cell level
Poster 
A multi-omic investigation of gene dysregulation in a complex chromothripsis-like translocation event using Oxford Nanopore sequencing
Poster 
Poster: structural and epigenetic profiling of D4Z4 arrays in FSHD using Oxford Nanopore sequencing
Video 
Oxford Nanopore sequencing of the UK Biobank | LC26
Video 
Nanopore sequencing reveals psilocybin-induced brain 5mC/5hmC epigenetic changes
Video 
Nanopore sequencing of intact, aminoacylated tRNA
Publication 
Nanopore sequencing of DNA-barcoded probes for highly multiplexed detection of microRNA, proteins and small biomarkers
Publication 
Nanopore-based consensus sequencing enables accurate multimodal tumour cell-free DNA profiling
Learning 
Multiomics with one platform: how do I see more from my samples with Oxford Nanopore sequencing?
Poster 
Multiomic data identifies skewed X-inactivation and its role in masking Mendelian inheritance patterns
Publication 
Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease
